SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
OSI
PHARMACEUTICALS INC
(Name of Issuer)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
671040103
(CUSIP Number)
Joel M. Frank
OZ Management, LP
9 West 57th Street, 39th Floor
New York, NY 10019
212-790-0000
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
May 18, 2010
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box
¨
.
Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section
240.13d-7 for other parties to whom copies are to be sent.
*
|
|
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
The information
required on the remainder of this cover page shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act) or otherwise subject to the liabilities of that
section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).
|
|
|
|
|
CUSIP No. 671040103
|
|
Schedule 13D
|
|
Page
2
of 11 pages
|
|
|
|
|
|
|
|
1.
|
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
OZ Management LP
|
2.
|
|
Check the Appropriate Box if a
Member of a Group (See Instructions)
(a)
¨
(b)
¨
|
3.
|
|
SEC USE ONLY
|
4.
|
|
Source of Funds (See
Instructions)
OO. See Item
3.
|
5.
|
|
Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)
¨
|
6.
|
|
Citizenship or Place of
Organization
Delaware
|
Number of
Shares
Beneficially
Owned by
E
ach
Reporting
Person
with
|
|
7.
|
|
Sole Voting Power
721,700
|
|
8.
|
|
Shared Voting Power
0
|
|
9.
|
|
Sole Dispositive Power
721,700
|
|
10.
|
|
Shared Dispositive Power
0
|
11.
|
|
Aggregate Amount Beneficially
Owned by Each Reporting Person
721,700
|
12.
|
|
Check if the Aggregate Amount in
Row (11) Excludes Certain Shares (See Instructions)
¨
|
13.
|
|
Percent of Class Represented by
Amount in Row (11)
1.21%
|
14.
|
|
Type of Reporting Person (See
Instructions)
IA
|
|
|
|
|
|
CUSIP No. 671040103
|
|
Schedule 13D
|
|
Page
3
of 11 pages
|
|
|
|
|
|
|
|
1.
|
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Och-Ziff Holding Corporation
|
2.
|
|
Check the Appropriate Box if a
Member of a Group (See Instructions)
(a)
¨
(b)
¨
|
3.
|
|
SEC USE ONLY
|
4.
|
|
Source of Funds (See
Instructions)
OO. See Item
3.
|
5.
|
|
Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)
¨
|
6.
|
|
Citizenship or Place of
Organization
Delaware
|
Number of
Shares
Beneficially
Owned by
E
ach
Reporting
Person
with
|
|
7.
|
|
Sole Voting Power
721,700
|
|
8.
|
|
Shared Voting Power
0
|
|
9.
|
|
Sole Dispositive Power
721,700
|
|
10.
|
|
Shared Dispositive Power
0
|
11.
|
|
Aggregate Amount Beneficially
Owned by Each Reporting Person
721,700
|
12.
|
|
Check if the Aggregate Amount in
Row (11) Excludes Certain Shares (See Instructions)
¨
|
13.
|
|
Percent of Class Represented by
Amount in Row (11)
1.21%
|
14.
|
|
Type of Reporting Person (See
Instructions)
CO
|
|
|
|
|
|
CUSIP No. 671040103
|
|
Schedule 13D
|
|
Page
4
of 11 pages
|
|
|
|
|
|
|
|
1.
|
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Och-Ziff Capital Management Group LLC
|
2.
|
|
Check the Appropriate Box if a
Member of a Group (See Instructions)
(a)
¨
(b)
¨
|
3.
|
|
SEC USE ONLY
|
4.
|
|
Source of Funds (See
Instructions)
OO. See Item
3.
|
5.
|
|
Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)
¨
|
6.
|
|
Citizenship or Place of
Organization
Delaware
|
Number of
Shares
Beneficially
Owned by
E
ach
Reporting
Person
with
|
|
7.
|
|
Sole Voting Power
750,000
|
|
8.
|
|
Shared Voting Power
0
|
|
9.
|
|
Sole Dispositive Power
750,000
|
|
10.
|
|
Shared Dispositive Power
0
|
11.
|
|
Aggregate Amount Beneficially
Owned by Each Reporting Person
750,000
|
12.
|
|
Check if the Aggregate Amount in
Row (11) Excludes Certain Shares (See Instructions)
¨
|
13.
|
|
Percent of Class Represented by
Amount in Row (11)
1.26%
|
14.
|
|
Type of Reporting Person (See
Instructions)
OO
|
|
|
|
|
|
CUSIP No. 671040103
|
|
Schedule 13D
|
|
Page
5
of 11 pages
|
|
|
|
|
|
|
|
1.
|
|
Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only)
Daniel S. Och
|
2.
|
|
Check the Appropriate Box if a
Member of a Group (See Instructions)
(a)
¨
(b)
¨
|
3.
|
|
SEC USE ONLY
|
4.
|
|
Source of Funds (See
Instructions)
OO. See Item
3.
|
5.
|
|
Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)
¨
|
6.
|
|
Citizenship or Place of
Organization
United States
|
Number of
Shares
Beneficially
Owned by
E
ach
Reporting
Person
with
|
|
7.
|
|
Sole Voting Power
750,000
|
|
8.
|
|
Shared Voting Power
0
|
|
9.
|
|
Sole Dispositive Power
750,000
|
|
10.
|
|
Shared Dispositive Power
0
|
11.
|
|
Aggregate Amount Beneficially
Owned by Each Reporting Person
750,000
|
12.
|
|
Check if the Aggregate Amount in
Row (11) Excludes Certain Shares (See Instructions)
¨
|
13.
|
|
Percent of Class Represented by
Amount in Row (11)
1.26%
|
14.
|
|
Type of Reporting Person (See
Instructions)
IN
|
|
|
|
|
|
CUSIP No. 671040103
|
|
Schedule 13D
|
|
Page
6
of 11 pages
|
Item 1.
|
Security and Issuer.
|
This statement on
Schedule 13D relates to the shares (the Shares) of common stock, $0.01 par value (the Common Stock), of OSI PHARMACEUTICALS INC (the Issuer). The principal executive office of the Issuer is located at 41 Pinelawn
Road, Melville, New York 11747.
Item 2.
|
Identity and Background.
|
(a)
|
This statement is filed by the entities and persons listed below, all of whom together are referred to herein as the Reporting Persons:
|
(i) OZ Management LP (OZ) and OZ Management II LP (OZII), Delaware limited partnerships,
are the principal investment managers to a number of investment funds and discretionary accounts managed by OZ and OZII (the Accounts) with respect to the Shares reported in this Schedule 13D.
(ii) Och-Ziff Holding Corporation (OZHC), a Delaware corporation, which serves as the general partner of OZ, with respect to
the Shares report in this Schedule 13D managed by OZ, OZII, and held by the Accounts.
(iii) Och-Ziff Holding Capital
Management Group LLC (OZM), a Delaware limited liability company, is a holding company which owns 100% of OZHC and Och-Ziff Holding LLC, a Delaware limited liability company, which serves as the general partner of another investment fund
with respect to the Shares reported in this Schedule 13D managed by OZ, OZII, and held by the accounts.
(iv) Daniel S. Och is
the Chief Executive Officer of OZHC and OZM, with respect to the Shares reported in this Schedule 13D managed by OZ, OZII, and held by the Accounts.
(b)
|
The address of the principal business office of each of the Reporting Persons is 9 West 57th Street, 39th Floor, New York, NY 10019.
|
(c)
|
None of the Reporting Persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
|
(d)
|
None of the Reporting Persons has, during the last five years, has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction
which resulted in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violations with respect to such laws.
|
(e)
|
The citizenship of OZ, OZHC, and OZM is set forth above. Daniel S. Och is a United States citizen.
|
Item 3.
|
Source and Amount of Funds or Other Consideration.
|
The Shares reported in Item 5 as beneficially owned by the Reporting Persons were acquired with funds of approximately $1,008,600 million (including
brokerage commissions). All funds to acquire the Shares were provided from capital of the Accounts.
The Shares reported herein were acquired
by the Reporting Persons for investment purposes and not with a view towards changing or influencing control of the Issuer. The Issuer is subject to a Tender Offer to Acquire all outstanding shares of the Issuer by Ruby Acquisition, Inc., a
wholly-owned subsidiary of
|
|
|
|
|
CUSIP No. 671040103
|
|
Schedule 13D
|
|
Page
7
of 11 pages
|
Astellas US Holding, Inc. as of March 1, 2010. Since some of the Shares were acquired following the public announcement of the tender offer, under interpretations of the Staff of the
Securities and Exchange Commission, the Reporting Persons may be deemed to have acquired the Shares in connection with the proposed takeover.
The Reporting Persons reserve the right to acquire, or cause to be acquired, additional securities of the Issuer or derivatives or other instruments
related thereto, to dispose of, or cause to be disposed of, such securities, derivatives or other instruments at any time and to formulate other purposes, plans or proposals regarding the Issuer or any of its securities, to the extent deemed
advisable in light of general investment and trading policies of the Reporting Persons, market conditions or other factors.
Except as set
forth herein, the Reporting Persons do not have any plans or proposals at this time that relate to or would result in any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.
Item 5.
|
Interest in Securities of the Issuer.
|
(a)
|
The aggregate percentage of Shares reported to be beneficially owned by the Reporting Persons is based upon 61,207,646 shares of Common Stock outstanding as of
May 3, 2010 as reflected in the Form 10Q filed by the Company for the quarterly period ended March 31, 2010.
|
As of the date of this filing:
(i) OZ and OZHC may be deemed to beneficially own 721,700* shares of Common Stock, constituting approximately 1.21%* of the shares of
Common Stock outstanding.
(ii) OZM and Mr. Och may be deemed to beneficially own 750,000* shares of Common Stock,
constituting approximately 1.26%* of the shares of Common Stock outstanding
*Includes 750,000 shares of Common Stock
receivable upon the exercise of call options held by the Reporting Persons.
(b)
|
Sole voting and dispositive powers of the Reporting Persons:
|
(i) OZ and OZHC have sole voting and dispositive powers over the 721,700* Shares reported herein.
(ii) OZM as the sole shareholder of both OZHC and Och-Ziff Holding LLC and may be deemed to control voting and dispositive power over the
750,000* Shares reported herein.
(iii) Mr. Och, as Chief Executive Officer of OZM may be deemed to control voting and
dispositive power over the 750,000* Shares reported herein.
(c)
|
Information concerning transactions in the Shares during the past sixty days effected by the Accounts for which the Reporting Persons have management and discretionary
authority is set forth in Schedule I hereto and is incorporated herein by reference.
|
(d)
|
No person other than the Accounts of OZ has the right to receive or the power to direct the receipt of dividends from, or the proceeds of the sale, of the securities
being reported herein.
|
|
|
|
|
|
CUSIP No. 671040103
|
|
Schedule 13D
|
|
Page
8
of 11 pages
|
Item 6.
|
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
|
The Reporting Persons may, from time to time, enter into and dispose of cash-settled equity swap or other similar derivative transactions with one or more
counterparties that are based upon the value of Common Stock of the Issuer, which transactions may be significant in amount. The profit, loss and/or return on such contracts may be wholly or partially dependent on the market value of the Common
Stock, the relative value of Common Stock in comparison to one or more other financial instruments, indexes or securities, a basket or group of securities in which Common Stock may be included, or a combination of any of the foregoing. These
contracts will not give the Reporting Persons direct or indirect voting, or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer.
Accordingly, the Reporting Persons disclaim any beneficial ownership in any securities that may be referenced in such contracts or that may be held from time to time by any counterparties to such contracts.
Except as described herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in
Item 2 hereof and between such persons and any person with respect to any securities of the Issuer, including but not limited to transfer or voting of any other securities, finders fees, joint ventures, loan or option arrangements, puts
or calls, guarantees of profits, divisions of profits or loss, or the giving or withholding of proxies.
Item 7.
|
Materials to Be Filed as Exhibits.
|
1.
Joint Acquisition Statement Pursuant to Rule 13d-1(k).
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
|
/
S
/ D
ANIEL
S.
O
CH
|
OZ MANAGEMENT LP
|
By Och-Ziff Holding Corporation,
its general partner;
|
By Daniel S. Och
|
Chief Executive Officer
|
|
/
S
/ D
ANIEL
S.
O
CH
|
Och-Ziff Holding Corporation
|
By Daniel S. Och
|
Chief Executive Officer
|
|
/
S
/ D
ANIEL
S.
O
CH
|
Och-Ziff Capital Management Group LLC
|
By Daniel S. Och
|
Chief Executive Officer
|
|
/
S
/ D
ANIEL
S.
O
CH
|
Daniel S. Och
|
Dated: May 26, 2010
SCHEDULE I
TRANSACTIONS IN THE PAST SIXTY DAYS BY THE ACCOUNTS
Unless otherwise indicated, each of the transactions described below was effected for cash on the New York Stock Exchange.
|
|
|
|
|
|
|
|
Date
|
|
Purchase / Sale
|
|
Number of Shares
|
|
Price per Share
|
3/1/2010
|
|
Purchase
|
|
175,000
|
|
$
|
55.55
|
3/1/2010
|
|
Purchase
|
|
342,178
|
|
$
|
55.62
|
3/3/2010
|
|
Purchase
|
|
407,787
|
|
$
|
56.80
|
3/3/2010
|
|
Purchase
|
|
75,000
|
|
$
|
57.00
|
3/4/2010
|
|
Purchase
|
|
122,392
|
|
$
|
56.44
|
3/4/2010
|
|
Purchase
|
|
120,000
|
|
$
|
56.53
|
3/4/2010
|
|
Purchase
|
|
78,769
|
|
$
|
56.55
|
3/4/2010
|
|
Purchase
|
|
697
|
|
$
|
56.69
|
3/5/2010
|
|
Purchase
|
|
159,780
|
|
$
|
56.41
|
3/5/2010
|
|
Purchase
|
|
1,149
|
|
$
|
56.81
|
3/11/2010
|
|
Sale
|
|
50,412
|
|
$
|
57.30
|
3/15/2010
|
|
Purchase
|
|
7,900
|
|
$
|
58.03
|
3/15/2010
|
|
Purchase
|
|
160,929
|
|
$
|
58.16
|
3/16/2010
|
|
Purchase
|
|
3,069
|
|
$
|
57.89
|
3/16/2010
|
|
Purchase
|
|
55,000
|
|
$
|
57.99
|
3/17/2010
|
|
Purchase
|
|
471
|
|
$
|
58.16
|
3/17/2010
|
|
Purchase
|
|
414,721
|
|
$
|
58.19
|
3/18/2010
|
|
Purchase
|
|
59,293
|
|
$
|
58.49
|
3/30/2010
|
|
Purchase
|
|
114,300
|
|
$
|
59.52
|
3/30/2010
|
|
Purchase
|
|
176,600
|
|
$
|
59.68
|
3/30/2010
|
|
Sale
|
|
5,953
|
|
$
|
60.21
|
3/30/2010
|
|
Sale
|
|
2,944
|
|
$
|
60.26
|
3/30/2010
|
|
Sale
|
|
9,413
|
|
$
|
60.29
|
4/1/2010
|
|
Purchase
|
|
60,000
|
|
$
|
59.57
|
4/1/2010
|
|
Purchase
|
|
56,327
|
|
$
|
59.60
|
5/11/2010
|
|
Purchase
|
|
68,100
|
|
$
|
57.04
|
5/11/2010
|
|
Purchase
|
|
28,449
|
|
$
|
57.02
|
5/12/2010
|
|
Purchase
|
|
89,814
|
|
$
|
57.23
|
5/13/2010
|
|
Purchase
|
|
55,000
|
|
$
|
57.07
|
5/13/2010
|
|
Purchase
|
|
71,014
|
|
$
|
57.32
|
5/13/2010
|
|
Purchase
|
|
25,000
|
|
$
|
57.38
|
5/14/2010
|
|
Sale
|
|
60,025
|
|
$
|
59.60
|
5/18/2010
|
|
Sale
|
|
850,000
|
|
$
|
57.35
|
5/19/2010
|
|
Sale
|
|
449,992
|
|
$
|
57.33
|
5/19/2010
|
|
Sale
|
|
1,500,000
|
|
$
|
57.34
|
EXHIBIT 1
JOINT ACQUISITION STATEMENT
PURSUANT TO RULE 13d-1(k)
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D, is filed on behalf of the undersigned and that all
subsequent amendments to this statement on Schedule 13D, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the
timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness or accuracy of the information concerning the others, except to the
extent that he or it know or has reason to believe that such information is inaccurate.
|
/
S
/ D
ANIEL
S.
O
CH
|
OZ MANAGEMENT LP
|
By Och-Ziff Holding Corporation,
its general partner;
|
By Daniel S. Och
|
Chief Executive Officer
|
|
/
S
/ D
ANIEL
S.
O
CH
|
Och-Ziff Holding Corporation
|
By Daniel S. Och
|
Chief Executive Officer
|
|
/
S
/ D
ANIEL
S.
O
CH
|
Och-Ziff Capital Management Group LLC
|
By Daniel S. Och
|
Chief Executive officer and
|
Executive Managing Director and
|
|
/
S
/ D
ANIEL
S.
O
CH
|
Daniel S. Och
|
Dated: May 26, 2010
Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Oct 2023 to Oct 2024